Compare Selvita SA with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 5.35%
- The company has been able to generate a Return on Capital Employed (avg) of 5.35% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
3
High Debt company with Weak Long Term Fundamental Strength
4
The company has declared Negative results for the last 4 consecutive quarters
5
With ROE of -0.92%, it has a risky valuation with a 2.51 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
PLN 642 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.32
0.25%
2.00
Revenue and Profits:
Net Sales:
93 Million
(Quarterly Results - Dec 2025)
Net Profit:
7 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-25.87%
0%
-25.87%
6 Months
-22.28%
0%
-22.28%
1 Year
-18.11%
0%
-18.11%
2 Years
-54.4%
0%
-54.4%
3 Years
-57.82%
0%
-57.82%
4 Years
-58.37%
0%
-58.37%
5 Years
-54.14%
0%
-54.14%
Selvita SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.61%
EBIT Growth (5y)
-21.24%
EBIT to Interest (avg)
4.94
Debt to EBITDA (avg)
1.60
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
0.75
Tax Ratio
49.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.35%
ROE (avg)
10.42%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.51
EV to EBIT
124.60
EV to EBITDA
14.77
EV to Capital Employed
2.09
EV to Sales
2.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.68%
ROE (Latest)
-0.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
92.60
88.10
5.11%
Operating Profit (PBDIT) excl Other Income
19.10
15.80
20.89%
Interest
3.60
2.40
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.30
-0.90
911.11%
Operating Profit Margin (Excl OI)
61.40%
28.00%
3.34%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 5.11% vs -5.78% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 911.11% vs 80.43% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
364.50
342.00
6.58%
Operating Profit (PBDIT) excl Other Income
61.80
48.90
26.38%
Interest
11.00
12.40
-11.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.80
-6.10
113.11%
Operating Profit Margin (Excl OI)
19.90%
-12.40%
3.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 6.58% vs -1.44% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 113.11% vs -108.73% in Dec 2024
About Selvita SA 
Selvita SA
Pharmaceuticals & Biotechnology
Selvita SA, formerly Selvita Cro SA, is a Poland-based integrated service company active in the pharmaceutical and biotechnology industries. The Company is engaged in providing multidisciplinary solutions supporting customers and projects within area of drug discovery, regulatory studies, as well as research and development. It offers its clients drug discovery support at every stage of the early discovery phase up to preclinical research, from target validation up to the selection of a clinical candidate. Also, it offers services at every stage of the drug discovery process in the field of drug testing and bioanalytical analyses, from development and validation of methods, stability studies, to routine quality control testing. The Company cooperates with numerous research institutes and universities from Europe and the United States.
Company Coordinates 
Company Details
Park Life Science, ul. Bobrzynskiego 14 , KRAKOW None : 30-348
Registrar Details






